Journal of Clinical Epidemiology
Volume 52, Issue 3 , Pages 187-192, March 1999

Generic and Specific Measurement of Health-Related Quality of Life in a Clinical Trial of Respiratory Rehabilitation

  • Gordon H. Guyatt

      Affiliations

    • Dr. Guyatt is a Career Scientist of the Ontario Ministry of Health.
    • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    • Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    • Corresponding Author InformationAddress correspondence to: Dr. G. Guyatt, Room 2C12, McMaster University Health Sciences Centre, 1200 Main Street West, Hamilton, Ontario, Canada, L8N 3Z5
  • ,
  • Derek R. King

      Affiliations

    • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
  • ,
  • David H. Feeny

      Affiliations

    • Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    • Centre for Health Economic and Policy Analysis, McMaster University, Hamilton, Ontario, Canada
  • ,
  • David Stubbing

      Affiliations

    • Department of Medicine, McMaster University, Hamilton, Ontario, Canada
  • ,
  • Roger S. Goldstein

      Affiliations

    • Department of Medicine, University of Toronto, Toronto, Ontario, Canada

Accepted 6 November 1998.

Abstract 

The purpose of this study was to compare the performance of measures of health-related quality of life in a randomized controlled trial of respiratory rehabilitation versus conventional community care for patients with chronic airflow limitation. The study included 89 stable patients with moderate to severe chronic airflow limitation with measurement of health status at 12, 18, and 24 weeks. Outcomes included two disease-specific (the Oxygen Cost Diagram and the Chronic Respiratory Questionnaire [CRQ]) measures, a generic health profile (the Sickness Impact Profile [SIP]), and two utility measures (the Standard Gamble and the Quality of Well-Being index [QWB]). Of the measures, only the four domains of the CRQ (dyspnea, fatigue, mastery, and emotional function) showed statistically significant differences (P ≤ 0.05) between treatment and control groups. Correlation between change in the CRQ and change in other relevant measures, including the 6-minute walk test and global ratings of change in dyspnea, fatigue, and emotional function were generally weak to moderate (from 0.19 to 0.51). All correlations between change in the QWB, SIP, and Standard Gamble and other measures were very weak or weak (up to 0.30). Correlation between change in the three generic measures were all very weak (<0.15). The results suggest that unless investigators include responsive and valid disease-specific measures of health-related quality of life in controlled trials in chronic diseases, they risk misleading conclusions about the effect of treatments on health status.

Keywords:  Quality of life, clinical epidemiology, clinical trials, functional status, chronic disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0895-4356(98)00157-7

Journal of Clinical Epidemiology
Volume 52, Issue 3 , Pages 187-192, March 1999